For research use only. Not for therapeutic Use.
c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer.
IC50 value:
Target: c-Met
More details please refer to Patent WO 2012015677 A1.
| Catalog Number | I001382 |
| CAS Number | 1357072-61-7 |
| Synonyms | 3-(2-methylindazol-5-yl)sulfanyl-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazine |
| Molecular Formula | C17H14N8S |
| Purity | ≥95% |
| InChI | InChI=1S/C17H14N8S/c1-23-10-12(8-18-23)15-5-6-16-19-20-17(25(16)22-15)26-13-3-4-14-11(7-13)9-24(2)21-14/h3-10H,1-2H3 |
| InChIKey | JYXHZDNTBJUJNH-UHFFFAOYSA-N |
| SMILES | CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=CN(N=C5C=C4)C)C=C2 |
| Reference | [1]. PCT Int. Appl. (2012), WO 2012015677 A1 20120202. |
